Differences

This shows you the differences between two versions of the page.

--- combating_antibiotic_resistant_bacteria_biopharmaceutical_accelerator [2022/06/06 09:54]
liam [Funding]
+++ — (current)
@@ Line 1: / Line 1: @@
-====== Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator ======
-{{ ::download_10_.png?200|}}
-The **Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)** is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria.
-===== Affiliations =====
-==== Funding ====
-CARB-X is funded by the [[Bill & Melinda Gates Foundation]], [[Biomedical Advanced Research and Development Authority]] (BARDA), [[German Federal Ministry of Education and Research]], [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[United Kingdom Department of Health and Social Care]] (through the [[Global Antimicrobial Resistance Innovation Fund]]), and the [[Wellcome Trust]].((//Funding Partners.// (2022). CARB-X. https://archive.ph/yoAo4))
-==== Global Accelerator Network ====
-CARB-X's Global Accelerator Network is composed of:((//Global Accelerator Network.// (2022). CARB-X. https://carb-x.org/partners/global-accelerator-network/))
-  * [[California Life Sciences]]
-  * [[Centre for Cellular and Molecular Platforms]] (C-CAMP)
-  * [[Foundation for Innovative New Diagnostics]] (FIND)
-  * [[German Center for Infectious Diseases]] (DZIF)
-  * [[Institute for Life Sciences Entrepreneurship]] (ILSE)
-  * [[RTI International]]